Cookies show us what works. Privacy
Cookies show us what works. Privacy
24 funds hold it · Insiders net selling
Net selling: insiders sold $108.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $7K to $105K in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 4, 2026
Financial period
Q3 2026
Earnings per share
$7.20 expected
Revenue
$1.36B expected
FY 2026 guidance
$5.34B to $5.36B
No comparable estimate
Estimates as of Nov 10, 2026
EPS expected
$7.61 to $7.75
Revenue expected
12 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 4, 2026 | $7.54est. $7.20 | +4.68%beat | $1.38Best. $1.36B+1.64% | +17.9%from $1.17B |
| Jun 30, 2026Reported Aug 5, 2026 | $7.00est. $6.58 | +6.30%beat | $1.34Best. $1.30B+2.99% | +21.5%from $1.10B |
| Mar 31, 2026Reported May 7, 2026 | $5.80est. $5.47 | +6.03%beat | $1.26BCompany release | +25.4%from $1.01B |
| Dec 31, 2025Reported Feb 4, 2026 | $6.04est. $5.94 | +1.68%beat | $1.25BAlpha Vantage | +20.7%from $1.03B |
| Sep 30, 2025Reported Nov 5, 2025 | $5.41est. $5.35 | +1.12%beat | $1.17BSEC filing | +13.9%from $1.03B |
| Jun 30, 2025Reported Aug 6, 2025 | $5.13est. $5.12 | +0.20%in line | $1.10BSEC filing | +12.9%from $975.7M |
| Mar 31, 2025Reported May 6, 2025 | $4.51est. $4.51 | +0.00%in line | $1.01BSEC filing | +7.5%from $935.3M |
| Dec 31, 2024Reported Feb 5, 2025 | $5.36est. $5.35 | +0.19%in line | $1.03BAlpha Vantage | +10.4%from $937.3M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.25B | $1.26B | $1.34B | $1.38B |
| Cost of what it sold | $376.7M | $344.5M | $275.2M | $298.1M |
| Gross profit | $871.6M | $916.5M | $1.06B | $1.08B |
| What it spent | ||||
| Sales and admin | $220.5M | $203.8M | $223.7M | $204.2M |
| Other operating costs | $140.1M | $169.6M | $368.8M | $258.4M |
| Total operating expenses | $360.5M | $373.4M | $592.5M | $462.6M |
| What was left | ||||
| Operating profit | $511.0M | $543.1M | $471.2M | $621.3M |
| Interest on debt | $113.0M | $110.1M | $114.7M | $108.8M |
| Profit before tax | $399.4M | $505.0M | $344.7M | $502.3M |
| Tax | $133.8M | $151.3M | $92.9M | $120.0M |
| Net profit | $264.5M | $350.1M | $248.3M | $378.4M |
| EBITDA | $629.0M | $729.9M | $577.7M | $726.7M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Q3 diversified financial services earnings: Donnelley Financial Solutions (NYSE:DFIN) earns top marks
Leans bullishNov 10QXO is Set to Report Q3 Earnings: Here's What Investors Should Know
Leans bullishNov 9Starling Oncology Q3FY26 Results: Revenue up 24% to $169.8 million
NeutralNov 6Ziff Davis Q3FY26 Results: Adj EPS beats est, revenue falls 5.6% to $289.3M
NeutralNov 6Disc Medicine enters sales agreement with TD Cowen for $189.93M stock offering
Leans bullishNov 6Jim Cramer Says Costco Is Still a Great Value. Charlie Munger’s Rule Explains Why
Leans bullishNov 5ACM Research Q3 Results: Adj. EPS $0.55 beats estimate, sales up 37%
Leans bullishNov 5Dynasty Hires Marketing Veteran From Coca-Cola, ESPN To Build Its Next Chapter
Leans bullishNov 421 macro signals shaping CPAY right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results